Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Liou

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Ebiomedicine|April 14, 2020
Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher diseaseYing Sun, Benjamin Liou, Zhengtao Chu, et al.
Plos One|March 23, 2013
Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher diseaseYing Sun, Wujuan Zhang, You-Hai Xu, et al.
Plos One|January 1, 2015
Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse modelSonya Barnes, You-Hai Xu, Wujuan Zhang, et al.
Cells|September 28, 2021
Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseYanyan Peng, Benjamin Liou, Yi Lin, et al.
Scientific Reports|April 5, 2019
Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotypeBenjamin Liou, Wujuan Zhang, Venette Fannin, et al.
Molecular Genetics and Metabolism|May 20, 2014
Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency diseaseYing Sun, You-Hai Xu, Hong Du, et al.
Plos One|May 3, 2011
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouseYing Sun, Huimin Ran, Benjamin Liou, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, <i>GBA1</i> mutation-associated pathologies and diseasesXiangli Zhao, Yi Lin, Benjamin Liou, et al.
Human Molecular Genetics|August 5, 2024
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher diseaseYi Lin, Xiangli Zhao, Benjamin Liou, et al.
Human Molecular Genetics|March 7, 2014
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceYou-hai Xu, Kui Xu, Ying Sun, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Ebiomedicine|April 14, 2020
Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher diseaseYing Sun, Benjamin Liou, Zhengtao Chu, et al.
Plos One|March 23, 2013
Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher diseaseYing Sun, Wujuan Zhang, You-Hai Xu, et al.
Plos One|January 1, 2015
Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse modelSonya Barnes, You-Hai Xu, Wujuan Zhang, et al.
Cells|September 28, 2021
Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseYanyan Peng, Benjamin Liou, Yi Lin, et al.
Scientific Reports|April 5, 2019
Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotypeBenjamin Liou, Wujuan Zhang, Venette Fannin, et al.
Molecular Genetics and Metabolism|May 20, 2014
Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency diseaseYing Sun, You-Hai Xu, Hong Du, et al.
Plos One|May 3, 2011
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouseYing Sun, Huimin Ran, Benjamin Liou, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, <i>GBA1</i> mutation-associated pathologies and diseasesXiangli Zhao, Yi Lin, Benjamin Liou, et al.
Human Molecular Genetics|August 5, 2024
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher diseaseYi Lin, Xiangli Zhao, Benjamin Liou, et al.
Human Molecular Genetics|March 7, 2014
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceYou-hai Xu, Kui Xu, Ying Sun, et al.
Pageof 4